Susquehanna International Group, LLP Relay Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$823 Billion
Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 136,889 shares of RLAY stock, worth $906,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,889

Previous 306,069 55.28%

Holding current value

$906,205

Previous $1.06 Million 32.51%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.22 - $5.22 $544,759 - $883,119	-169,180 Reduced 55.28%	136,889 $714,000
Q2 2025 Aug 14, 2025	BUY	$2.0 - $3.49 $98,572 - $172,008	49,286 Added 19.19%	306,069 $1.06 Million
Q1 2025 May 14, 2025	BUY	$2.62 - $4.92 $472,818 - $887,887	180,465 Added 236.46%	256,783 $672,000
Q4 2024 Feb 14, 2025	BUY	$4.12 - $6.8 $139,791 - $230,724	33,930 Added 80.05%	76,318 $314,000
Q3 2024 Nov 14, 2024	SELL	$6.23 - $9.51 $74,778 - $114,148	-12,003 Reduced 22.07%	42,388 $300,000

Q2 2024 Aug 15, 2024	SELL	$5.9 - $8.02 $55,041 - $74,818	-9,329 Reduced 14.64%	54,391 $354,000
Q1 2024 May 07, 2024	BUY	$7.5 - $12.07 $195,615 - $314,809	26,082 Added 69.3%	63,720 $528,000
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $1.06 Million - $2.03 Million	-177,137 Reduced 82.48%	37,638 $414,000
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $1.28 Million - $2.01 Million	155,358 Added 261.47%	214,775 $1.81 Million
Q2 2023 Aug 11, 2023	SELL	$9.99 - $18.27 $1.95 Million - $3.57 Million	-195,480 Reduced 76.69%	59,417 $746,000
Q1 2023 May 16, 2023	BUY	$15.0 - $22.76 $3.28 Million - $4.98 Million	218,782 Added 605.79%	254,897 $4.2 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $977,578 - $1.66 Million	-69,038 Reduced 65.65%	36,115 $539,000
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $359,882 - $624,764	19,916 Added 23.37%	105,153 $2.35 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $137,851 - $361,252	10,357 Added 13.83%	85,237 $1.43 Million
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $395,353 - $631,473	-19,514 Reduced 20.67%	74,880 $2.24 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $1.02 Million - $1.46 Million	39,328 Added 71.42%	94,394 $2.9 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $595,981 - $761,053	20,033 Added 57.18%	55,066 $1.74 Million
Q2 2021 Aug 11, 2021	SELL	$27.5 - $38.19 $1.32 Million - $1.83 Million	-47,966 Reduced 57.79%	35,033 $1.28 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $2.32 Million - $4.38 Million	71,228 Added 605.11%	82,999 $2.87 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $417,988 - $635,987	11,771 New	11,771 $489,000

Others Institutions Holding RLAY

# of Institutions

218

Shares Held

168M

Call Options Held

714K

Put Options Held

14.9K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $796M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Relay Therapeutics, Inc. Transaction History